Literature DB >> 10331412

Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models.

W Regittnig1, Z Trajanoski, H J Leis, M Ellmerer, A Wutte, G Sendlhofer, L Schaupp, G A Brunner, P Wach, T R Pieber.   

Abstract

Recent experimental evidence suggests that estimates of glucose effectiveness (S(G)) from the minimal model of unlabeled glucose disappearance (Cold-MM) are in error. The single-compartment glucose distribution assumption embedded in the model has been indicated as a possible source of error. In this study, to directly examine the single-compartment assumption, we measured plasma and interstitial glucose concentrations after intravenous glucose injection. Additionally, we compared the accuracy of the estimates of glucose effectiveness from the Cold-MM and the single-compartment tracer minimal model (Hot-MM). Paired labeled intravenous glucose tolerance tests (IVGTTs) were performed in each of six C-peptide-negative type 1 diabetic subjects. Two different insulin infusion protocols were used: an infusion at constant basal rates and an infusion at variable rates to mimic a normal insulin response. During the labeled IVGTT with basal insulin infusion, the microperfusion technique was employed to sample adipose tissue interstitial fluid. Marked differences between the plasma and interstitial dynamics of (cold) glucose were observed during the first 22 min after glucose injection. These results suggest that the requirements for a single-compartment representation of glucose kinetics are not satisfied during at least the first 22 min of an IVGTT. Data from the labeled IVGTT with normal insulin response were used to identify the minimal-model parameters. The measure of S(G) derived using the Cold-MM was 3.44-fold higher than the direct measure obtained from the labeled IVGTT with basal insulin infusion (0.0179+/-0.0027 vs. 0.0052+/-0.0010 min(-1), P<0.01). The measure of glucose effectiveness (S(G)*) derived by the Hot-MM was 1.36-fold higher than the direct measure available from the labeled IVGTT with basal insulin infusion (0.0079+/-0.0013 vs. 0.0058+/-0.0004 min(-1), P>0.26). These results suggest that the Hot-MM is more appropriate for the evaluation of glucose effectiveness than the Cold-MM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331412     DOI: 10.2337/diabetes.48.5.1070

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

Review 1.  Comparison of equivalence and determination of diagnostic utility of min-mod and clamp methods for insulin resistance in diabetes free subjects: a meta-analysis.

Authors:  Antonio Gordillo-Moscoso; J Francisco Valadéz-Castillo; Peter B Mandeville; J Francisco Hernández-Sierra
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

2.  Parenteral glucose and glucose control in the critically ill: a kinetic appraisal.

Authors:  Roman Hovorka; Jeremy Cordingley
Journal:  J Diabetes Sci Technol       Date:  2007-05

3.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

4.  Control oriented model of insulin and glucose dynamics in type 1 diabetics.

Authors:  Pier Giorgio Fabietti; Valentina Canonico; Marco Orsini Federici; Massimo Massi Benedetti; Eugenio Sarti
Journal:  Med Biol Eng Comput       Date:  2006-03       Impact factor: 2.602

5.  The identification of insulin saturation effects during the dynamic insulin sensitivity test.

Authors:  Paul D Docherty; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; J Lin; Kirsten A McAuley; Geoffrey M Shaw
Journal:  Open Med Inform J       Date:  2010-07-27

6.  The Effects of Additional Local-Mixing Compartments in the DISST Model-Based Assessment of Insulin Sensitivity.

Authors:  Nicholas Lam; Rua Murray; Paul D Docherty; Lisa Te Morenga; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2021-06-11

7.  A Generic Integrated Physiologically based Whole-body Model of the Glucose-Insulin-Glucagon Regulatory System.

Authors:  S Schaller; S Willmann; J Lippert; L Schaupp; T R Pieber; A Schuppert; T Eissing
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.